Roger Packer, MD Interim Division Chief, Neurology

Locations

Languages Spoken

  • English

Departments

Board Certifications

  • American Board of Pediatrics
  • American Board of Psychiatry/Neurology-Child Neuro
Bio

Biography

Roger J. Packer, MD, is Senior Vice-President, Center for Neuroscience and Behavioral Medicine, Gilbert Distinguished Professor of Neurofibromatosis, and is Director of both the Gilbert Neurofibromatosis Institute and the Brain Tumor Institute of Children’s National Health System. Dr. Packer’s present academic titles include Professor of Neurology and Pediatrics at George Washington University and Clinical Professor of Neurosurgery at the University of Virginia in Charlottesville, Virginia. Prior to coming to Children’s National, Dr. Packer was Director of the Brain Tumor Program and Professor of Neurology and Pediatrics at the Children’s Hospital of Philadelphia, University of Pennsylvania.

Throughout his career, Dr. Packer has been heavily involved in clinical and applied basic science research. His clinical research has touched on various aspects of adult and child neurology and neuro-oncology, including adult and pediatric brain tumors, neurofibromatosis type 1, the neurologic aspects of childhood neurogenetic diseases, and multiple other topics in general child neurology. Much of his research has focused on the development and performance of clinical trials for adults and children with neurologic, neuro-oncologic, and neurogenetic disorders, and he has received peer-reviewed grant support for this research. Many of the clinical trials in Neurofibromatosis and brain tumors are translational, bringing advances from the bench to the bedside expeditiously.

Presently, Dr. Packer is principal investigator at Children’s National for the Pediatric Brain Tumor Consortium (PBTC), formed under the auspices of the National Cancer Institute; Chairman of the PBTC Low-Grade Glioma Committee; Group Chair of the Neurofibromatosis Clinical Trials Consortium; is Chair of the Medulloblastoma Committee of the Children’s Oncology Group; P.I. for the Institution as part of the NINDS-sponsored Neuro-NEXT Clinical Trials Consortium; and P.I. of its NSADA award.  He has worked closely with the NCI and NINDS, and has served on multiple committees setting the directions for neurologic clinical and basic science research for the future. He headed the efforts in pediatrics for the program review, held by the NCI and NINDS, for brain tumors. Much of Dr. Packer’s clinical research has been translational in nature. He has been part of studies evaluating the molecular genetics of childhood and adult neurologic diseases and also has coordinated the first gene therapy study for children with malignant brain tumors in the U.S. The majority of the studies now being coordinated by Dr. Packer are studies evaluating innovative agents aimed at the molecular underpinnings of neurologic disease. He has published over 325 original articles and 300 reviews and chapters.

Education & Training

Education & Training

  • Fellowship Program, Pediatric Neurology, 1981
    Children's Hospital of Philadelphia
  • Fellowship Program, Neurology, 1981
    Children's Hospital of Philadelphia
  • Fellowship Program, Pediatric Neuro-Oncology, 1981
    Memorial Sloan-Kettering Cancer Center
  • Residency Program, Pediatrics, 1978
    Cincinnati Children's Hospital Medical Center
  • MD, 1976
    Northwestern University Feinberg School of Medicine
  • BS, 1972
    Northwestern University
Patient Stories

Patient Stories: Roger Packer

Patient story

Elias's Story Part Three

"As a parent of young children, you know that kids will do the darndest things. So do the best you can, keep your eyes open, but don't beat yourself up if you have to get a new broviac."

Patient story

Elias's Story Part Two

"One positive thing I have to say about this process is that the rotation of Children's attending physicians for the oncology inpatient unit is outstanding, and the fellows also are very good. They were accessible (by phone, too, when we were at home), understanding, and of course knowledgeable."

Patient story

Mason's Story

"You are about to embark on a journey that will be the challenge of your life as a parent. But you have chosen a hospital and a brain tumor treatment team that is one of the best in the country."

Patient story

Merrill's Story

"I think his medical experiences as a small child helped develop his attitude and approaches for coping. He still thinks of Children's as a friendly, good place, which is a real tribute to the excellent care and treatment he received."

Patient story

Amaya's Story

"Amaya is doing great. She has had two MRIs since (every three months) and all is well. She will begin track season healthy and strong!"

Keith's Story

"You will find new strength you didn't know you had. You will find that what seemed to be the daily grind of work or home life will take on new meaning and will sustain you by the sheer normalness of it."

Patient story

Kayla's Story

"If we had not come to Children's National for a second opinion, our daughter might not be alive today."

Patient story

Elias's Story

"No matter whom we saw on any day, we always felt Eli had a roomful of experts behind him."

Jackson's Story

"I have become a total advocate for my child, fighting this fight right alongside of him."

News

News

Research & Publications

Research & Publications

Biologic background of pediatric medulloblastoma and ependymoma A review from a translational research standpoint

(2008) Neuro-Oncology

Central nervous system germ cell tumors of childhood presentation and delay in diagnosis

(2007) Neurology

Long term outcome among adult survivors of childhood central nervous system malignancies A report from the Childhood Cancer Survivor Study

(2009) Journal of the National Cancer Institute

Long term outcome among adult survivors of childhood central nervous system malignancies A report from the Childhood Cancer Survivor Study

(2009) Journal of the National Cancer Institute

Massachusetts General Hospital Neurology Grand Rounds

(2011) Improved Outcome for Children with Medulloblastoma in the Molecular Era

Medulloblastoma in childhood new biologic advances

(2007) Lancet Neurology

Minneapolis Childrens Hospital Pediatric Grand Rounds

(2011) Molecular Insights of Medulloblastoma: Towards More Effective Therapy

Objective response of multiply recurrent low grade gliomas to bevicizumab and irinotecan

(2009) Pediatric Blood and Cancer

Phase I study of concurrent RMP7 and carbopatin with radiation therapy for children with newly diagnosed brainstem gliomas

(2005) Cancer

Phase I trial of pirfenidone in children with neurofibromatosis type 1 and plexiform neurofibromas

(2007) Journal of Pediatric Neurology

Phase III prospective randomized study of craniospinal radiation therapy followed by one of two adjuvant chemotherapy regimens for newly diagnosed average risk medulloblastoma

(2006) Journal of Clinical Oncology

View publications on PubMed

Invest in future cures for some of life's most devastating diseases

See other ways to give

Keep in touch with Children's National by signing up for our newsletters.

Sign up now

Elias's Story Part Three

Patient story

"As a parent of young children, you know that kids will do the darndest things. So do the best you can, keep your eyes open, but don't beat yourself up if you have to get a new broviac."

Read More of Elias's Story Part Three

Children's National in Your Neighborhood

A location marker

Did you know Children’s National has more than 50 locations throughout the region? Find one that’s convenient for your family.

Find a Children's Location Near You